logo
  • Home
  • Company
    • Management
    • Board of Directors
    • Governance
    • Medical and Scientific Advisory Board
  • Investors
    • Overview
    • News / Events
    • Shareholder Calls / Presentations
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • News & Media
    • Press Releases
    • Articles
    • Reports
    • Media
    • Photo Gallery
  • Contact
    • Social Media Community Guidelines

Annual Reports

Navigation Toggle Navigation
  • Overview
  • News / Events
  • Shareholder Calls / Presentations
  • Company Information
  • Financial Information
  • Stock Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Corporate Governance
  • Quick Links
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed
Filter Filings:
Date Form Description Docs XBRL Pages
08/01/11 NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT HTML PDF 3
04/26/11 10-K/A Annual report pursuant to Section 13 and 15(d)
Related Documents
EX-31
EX-32
HTML PDF 53
12/29/10 10-K Annual report pursuant to Section 13 and 15(d)
Related Documents
EX-21
EX-31
EX-32
HTML PDF 55
07/30/10 NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT HTML PDF 4
08/13/09 10-K Annual report pursuant to Section 13 and 15(d)
Related Documents
EX-21
EX-2
EX-31
EX-32
EX-10
EX-3
EX-3
HTML PDF 79
07/29/09 NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT HTML PDF 4
07/29/08 10KSB Optional form for annual and transition reports of small business issuers [Section 13 or 15(d), not S-B Item 405]
Related Documents
EX-21
HTML PDF 29
08/07/07 10KSB Optional form for annual and transition reports of small business issuers [Section 13 or 15(d), not S-B Item 405] HTML PDF 29
07/30/07 NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT HTML PDF 2
08/14/06 10KSB Optional form for annual and transition reports of small business issuers [Section 13 or 15(d), not S-B Item 405]
Related Documents
EX-31
EX-32
HTML PDF 34
RSS
  • << Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next >>

Contact Us

PharmaCyte Biotech, Inc.
3960 Howard Hughes Parkway, Suite 500
Las Vegas, Nevada 89169
Office Number: 917.595.2850
Facsimile Number: 917.595.2851
Email: info@PharmaCyte.com

Latest News

  • PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease May 21, 2024
  • PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc. November 15, 2023